Czech Rheumatology - Issue 1/2009
Original Papers
4
The Czech Rheumatological Society recommendations for monitoring the treatment safety in rheumatoid arthritis
L. Šedová, J. Štolfa, P. Horák, K. Pavelka
17
Impact of modification of implants for replacement of osteochondral defects on the gene expression of chondrocytes
M. Polanská, H. Hulejová, M. Petrtýl, Z. Bastl, Z. Kruliš, Z. Horák, D. Veigl, L. Šenolt
23
Collagen and elastin degradation products as potential activity markers of scleroderma
R. Bečvář, J. Štork, H. Hulejová, M. Braun, I. Zatloukalová, P. Zatloukal, P. Jansa, T. Paleček
Overview Reports
30
36
News in the biological therapy of rheumatoid arthritis and future prospects
L. Šenolt, J. Vencovský
Case Report
51
Rituximab in the treatment of Wegener’s granulomatosis non-responsive to standard therapy
P. Němec, J. Vlček, V. Postránecká, A. Krpenský, M. Souček
Czech Rheumatology
2009 Číslo 1
Najčítanejšie v tomto čísle
- Interleukin 6 in rheumatic diseases
- News in the biological therapy of rheumatoid arthritis and future prospects
- Rituximab in the treatment of Wegener’s granulomatosis non-responsive to standard therapy
- Collagen and elastin degradation products as potential activity markers of scleroderma